Maroua Slouma, Takwa Mehmli, Emna Hannech, Rim Dhahri, Islam Mejri, Meriem Affes, Imen Gharsallah
{"title":"斯约格伦综合征与强直性脊柱炎的关联:基于病例的回顾。","authors":"Maroua Slouma, Takwa Mehmli, Emna Hannech, Rim Dhahri, Islam Mejri, Meriem Affes, Imen Gharsallah","doi":"10.2174/0115733971315532240920065136","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Unlike restrictive pulmonary function and apical fibrobullous disease, diffuse interstitial lung disease is scarce in patients with ankylosing spondylitis (AS). We present a systematic review of the association between AS and SS. We also report a new case of SS revealed by interstitial lung disease in AS patients treated with tumor necrosis factor (TNF) inhibitors.</p><p><strong>Materials and methods: </strong>The systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline using the MEDLINE and SCOPUS databases and included case reports and case series describing the association between AS and SS.</p><p><strong>Results: </strong>There were sixty-three patients, including our case: 16 males and 47 females. The mean age was 49.2 years. The mean SpA duration was 14.1 years. The mean delay between SpA and SS was 12.8 years (0-27). SS was diagnosed after SpA in 62% of cases (n=39). It preceded SpA in 36.5% (n=23) and was concomitant with SpA in 1 case. All patients had sicca symptoms. MSGB showed focal sialadenitis grade III or grade IV in the Chisholm classification in 20 patients. Anti- nuclear antibody was positive in 75.8% of cases. Among them, anti-SSA and anti-SSB were positive in 44.4% and 35.3% of cases. Except for our patient, no patient had interstitial lung disease. SS extra glandular manifestations were reported in 12 cases.</p><p><strong>Conclusion: </strong>The occurrence of Sjögren's syndrome is uncommon in patients with ankylosing spondylitis. This association has been reported in the literature, suggesting a pathogenetic link between these two diseases. This association should be considered in ankylosing spondylitis patients with diffuse interstitial lung disease. Knowing this association is necessary for therapeutic adjustment. Our study has some limitations. Publication bias was the major bias in our study. Indeed, we only included case reports and case series describing the association between SpA and SS. We did not search for unpublished work. Moreover, the follow-up was not specified in most included articles.</p>","PeriodicalId":11188,"journal":{"name":"Current rheumatology reviews","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sjögren's Syndrome and Ankylosing Spondylitis Association: A Case-Based Review.\",\"authors\":\"Maroua Slouma, Takwa Mehmli, Emna Hannech, Rim Dhahri, Islam Mejri, Meriem Affes, Imen Gharsallah\",\"doi\":\"10.2174/0115733971315532240920065136\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Unlike restrictive pulmonary function and apical fibrobullous disease, diffuse interstitial lung disease is scarce in patients with ankylosing spondylitis (AS). We present a systematic review of the association between AS and SS. We also report a new case of SS revealed by interstitial lung disease in AS patients treated with tumor necrosis factor (TNF) inhibitors.</p><p><strong>Materials and methods: </strong>The systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline using the MEDLINE and SCOPUS databases and included case reports and case series describing the association between AS and SS.</p><p><strong>Results: </strong>There were sixty-three patients, including our case: 16 males and 47 females. The mean age was 49.2 years. The mean SpA duration was 14.1 years. The mean delay between SpA and SS was 12.8 years (0-27). SS was diagnosed after SpA in 62% of cases (n=39). It preceded SpA in 36.5% (n=23) and was concomitant with SpA in 1 case. All patients had sicca symptoms. MSGB showed focal sialadenitis grade III or grade IV in the Chisholm classification in 20 patients. Anti- nuclear antibody was positive in 75.8% of cases. Among them, anti-SSA and anti-SSB were positive in 44.4% and 35.3% of cases. Except for our patient, no patient had interstitial lung disease. SS extra glandular manifestations were reported in 12 cases.</p><p><strong>Conclusion: </strong>The occurrence of Sjögren's syndrome is uncommon in patients with ankylosing spondylitis. This association has been reported in the literature, suggesting a pathogenetic link between these two diseases. This association should be considered in ankylosing spondylitis patients with diffuse interstitial lung disease. Knowing this association is necessary for therapeutic adjustment. Our study has some limitations. Publication bias was the major bias in our study. Indeed, we only included case reports and case series describing the association between SpA and SS. We did not search for unpublished work. Moreover, the follow-up was not specified in most included articles.</p>\",\"PeriodicalId\":11188,\"journal\":{\"name\":\"Current rheumatology reviews\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2024-11-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current rheumatology reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0115733971315532240920065136\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"RHEUMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current rheumatology reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115733971315532240920065136","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
导言:与限制性肺功能和根尖纤维性疾病不同,强直性脊柱炎(AS)患者很少出现弥漫性间质性肺疾病。我们对强直性脊柱炎和间质性肺病之间的关系进行了系统回顾。此外,我们还报告了一例接受肿瘤坏死因子(TNF)抑制剂治疗的强直性脊柱炎患者因间质性肺病而引发的SS新病例:根据《系统综述和荟萃分析首选报告项目》指南,使用 MEDLINE 和 SCOPUS 数据库进行了系统综述,纳入了描述强直性脊柱炎与 SS 相关性的病例报告和系列病例:结果:包括我们的病例在内,共有 63 例患者:结果:包括我们的病例在内,共有 63 例患者,其中男性 16 例,女性 47 例。平均年龄为 49.2 岁。SpA 的平均持续时间为 14.1 年。SpA 和 SS 之间的平均延迟时间为 12.8 年(0-27)。62%的病例(39 人)在 SpA 后诊断出 SS。36.5%的病例(23人)在SpA之前被诊断为SS,1例在SpA的同时被诊断为SS。所有患者均有眼部症状。根据 Chisholm 分级,20 例患者的 MSGB 显示局灶性唾液腺炎 III 级或 IV 级。75.8%的病例抗核抗体呈阳性。其中,分别有 44.4% 和 35.3% 的病例抗 SSA 和抗 SSB 呈阳性。除本例患者外,其他患者均无间质性肺病。12例患者出现了SS腺体外表现:结论:强直性脊柱炎患者出现斯约格伦综合征并不常见。结论:强直性脊柱炎患者发生斯约格伦综合征的情况并不常见,文献中也有相关报道,这表明这两种疾病之间存在病因学联系。对于患有弥漫性间质性肺病的强直性脊柱炎患者,应考虑到这一关联。了解这种关联对于调整治疗方法很有必要。我们的研究存在一些局限性。发表偏倚是我们研究的主要偏倚。事实上,我们只纳入了描述 SpA 与 SS 之间关联的病例报告和系列病例。我们没有搜索未发表的研究成果。此外,大多数纳入的文章都没有明确说明随访情况。
Sjögren's Syndrome and Ankylosing Spondylitis Association: A Case-Based Review.
Introduction: Unlike restrictive pulmonary function and apical fibrobullous disease, diffuse interstitial lung disease is scarce in patients with ankylosing spondylitis (AS). We present a systematic review of the association between AS and SS. We also report a new case of SS revealed by interstitial lung disease in AS patients treated with tumor necrosis factor (TNF) inhibitors.
Materials and methods: The systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline using the MEDLINE and SCOPUS databases and included case reports and case series describing the association between AS and SS.
Results: There were sixty-three patients, including our case: 16 males and 47 females. The mean age was 49.2 years. The mean SpA duration was 14.1 years. The mean delay between SpA and SS was 12.8 years (0-27). SS was diagnosed after SpA in 62% of cases (n=39). It preceded SpA in 36.5% (n=23) and was concomitant with SpA in 1 case. All patients had sicca symptoms. MSGB showed focal sialadenitis grade III or grade IV in the Chisholm classification in 20 patients. Anti- nuclear antibody was positive in 75.8% of cases. Among them, anti-SSA and anti-SSB were positive in 44.4% and 35.3% of cases. Except for our patient, no patient had interstitial lung disease. SS extra glandular manifestations were reported in 12 cases.
Conclusion: The occurrence of Sjögren's syndrome is uncommon in patients with ankylosing spondylitis. This association has been reported in the literature, suggesting a pathogenetic link between these two diseases. This association should be considered in ankylosing spondylitis patients with diffuse interstitial lung disease. Knowing this association is necessary for therapeutic adjustment. Our study has some limitations. Publication bias was the major bias in our study. Indeed, we only included case reports and case series describing the association between SpA and SS. We did not search for unpublished work. Moreover, the follow-up was not specified in most included articles.
期刊介绍:
Current Rheumatology Reviews publishes frontier reviews on all the latest advances on rheumatology and its related areas e.g. pharmacology, pathogenesis, epidemiology, clinical care, and therapy. The journal"s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in rheumatology.